openPR Logo
Press release

Opioid Induced Constipation (OIC) Drugs Market | Industry Insights as Per Analysis, Latest Study & Research Report 2031

08-31-2023 09:54 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Opioid Induced Constipation (OIC) Drugs Market

Opioid Induced Constipation (OIC) Drugs Market

Opioid-induced constipation (OIC) is a common side effect experienced by patients who take opioid medications for pain management. Opioids bind to receptors in the gastrointestinal tract, slowing down bowel movements and leading to constipation. To address this issue, specific drugs have been developed to target OIC and provide relief to patients. The global opioid induced constipation (OIC) drugs market was valued at $1105.71 million in 2021, and is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.

โ™ฆ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ -
https://www.alliedmarketresearch.com/request-sample/13745

One class of drugs used to manage OIC is known as peripherally acting mu-opioid receptor antagonists (PAMORAs). These medications, such as naloxegol and methylnaltrexone, work by selectively blocking opioid receptors in the gut without affecting pain relief in other areas. By reversing the constipating effects of opioids, PAMORAs help restore normal bowel function and alleviate OIC symptoms.

Major market players covered in the report, such as -

AstraZeneca plc,
cosmo pharmaceuticals,
Dr. Reddy's Laboratories Ltd.,
Mallinckrodt plc,
Novartis AG,
Teva Pharmaceutical Industries Ltd.,
Shionogi & Co., Ltd.,
Bausch Health Companies Inc.,
Merck & Co., Inc.,
Takeda Pharmaceutical Company Limited

โ™ฆ ๐๐ซ๐จ๐œ๐ฎ๐ซ๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐Ÿ๐Ÿ๐ŸŽ ๐๐š๐ ๐ž๐ฌ ๐๐ƒ๐… ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐‚๐ก๐š๐ซ๐ญ๐ฌ, ๐“๐š๐›๐ฅ๐ž๐ฌ, ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ) @
https://www.alliedmarketresearch.com/opioid-induced-constipation-oic-drugs-market/purchase-options

Key Benefits for Stakeholders -

โ€ข The report provides quantitative analysis of market segments, current trends, strategies and potential of Opioid Induced Constipation (OIC) Drugs Market research to identify potential Opioid Induced Constipation (OIC) Drugs Market opportunities in genetics.
โ€ข In-depth analysis of this sector helps identify current market opportunities.
โ€ข Market analysis and information related to key drivers, restraints and opportunities are provided. โ€ข Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
โ€ข The largest countries in each region are listed according to their contribution to the global market.
โ€ข Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
โ€ข The report includes regional and global Opioid Induced Constipation (OIC) Drugs Market analysis, key players, market segments, application areas and Market growth strategies.

Another approach to managing OIC involves the use of stool softeners, laxatives, and bowel stimulants. These drugs, such as polyethylene glycol (PEG) and stimulant laxatives like bisacodyl, promote bowel movement by increasing water content in the intestines or stimulating the muscles in the gastrointestinal tract. They help soften the stool and relieve constipation caused by opioid use.

It is worth noting that the choice of OIC drug depends on factors such as the severity of constipation, individual patient characteristics, and the specific opioid being used. Healthcare providers work closely with patients to determine the most suitable treatment option and adjust medication regimens accordingly. Managing OIC effectively is crucial to ensure optimal pain management and improve the overall quality of life for patients taking opioids for chronic pain conditions.

โ™ฆ ๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐„๐ง๐ช๐ฎ๐ข๐ซ๐ฒ -
https://www.alliedmarketresearch.com/purchase-enquiry/13745

Frequently Asked Questions?

Q1. What is the total market value of Opioid Induced Constipation (OIC) Drugs Market report?

Q2. Which are the top companies holding the market share in Opioid Induced Constipation (OIC) Drugs Market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of Opioid Induced Constipation (OIC) Drugs Market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the Opioid Induced Constipation (OIC) Drugs Market report?

๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Induced Constipation (OIC) Drugs Market | Industry Insights as Per Analysis, Latest Study & Research Report 2031 here

News-ID: 3191171 • Views: โ€ฆ

More Releases from Allied Market Research

Extended Warranty Market Expected to Reach $286.4 Billion by 2032
According to a recent report by Allied Market Research titled, "Extended Warranty Market," the global extended warranty market was valued at $129.65 billion in 2022 and is projected to reach $286.4 billion by 2032, registering a CAGR of 8.4% from 2023 to 2032. Get a Sample Copy of this Report : https://www.alliedmarketresearch.com/request-sample/5022 The extended warranty market represents a vital segment of the insurance industry, offering consumers the option to purchase additional coverageโ€ฆ
Business Credit Cards Market Set to Reach $59.9B Globally by 2032 at 7% CAGR
Allied Market Research has released a new report titled, "Business Credit Cards Market by Type (Open-Loop Card and Closed-Loop Card) and Application (Small Business Credit Cards and Corporate Credit Cards): Global Opportunity Analysis and Industry Forecast, 2024-2032." According to the report, the business credit cards market was valued at $33.5 billion in 2023 and is projected to reach $59.9 billion by 2032, growing at a CAGR of 7% from 2024โ€ฆ
Parametric Insurance Market Expected to Reach $34.4 Billion by 2033
According to a new report published by Allied Market Research, titled "Parametric Insurance Market by Type (Natural Catastrophes Insurance, Specialty Insurance, Others), by Industry Vertical (Agriculture, Aerospace and Defense, Mining, Construction, Energy and Utilities, Manufacturing, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033," the global parametric insurance market was valued at $18 billion in 2023 and is projected to reach $34.4 billion by 2033, registering a CAGR of 6.6% fromโ€ฆ
Employment Screening Services Market Expected to Reach $19.6 Billion by 2033
According to a new report published by Allied Market Research, titled, "Employment Screening Services Market," The employment screening services market size was valued at $6.6 billion in 2023, and is estimated to reach $19.6 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033. Employment screening services refer to a range of background check processes employed by organizations to verify the qualifications, history, and overall suitability ofโ€ฆ

All 5 Releases


More Releases for OIC

Opioid-Induced Constipation (OIC) Drug Market Will Generate Record Revenue by 20 โ€ฆ
Opioid-Induced Constipation (OIC) Drug Market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market growth includes rising number of geriatric patients as these patients use opioid analgesics such as morphine, hydromorphone, codeine, etc. as a prescription for chronic non-cancer pain which has severe adverse effects on the digestive system resulting in huge demand for OIC drugs. Forโ€ฆ
Targeted Treatment Options For Opioid-Induced Constipation (OIC) In Global Marke โ€ฆ
Opioids are prescription drugs taken for treatment of chronic pain. While they relieve the pain, they can give opioid-induced constipation. The adverse effects associated with the opioids are decreasing gastrointestinal tractโ€™s motility, making patientโ€™s strain, and making of solid discharges. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The opioid-induced constipation treatment market is growing at a significant rate owingโ€ฆ
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018 - Research By Marke โ€ฆ
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC) (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, itsโ€ฆ
Opioid-Induced Constipation (OIC) - Complete Analysis on Therapeutics by Stage o โ€ฆ
A new research document is added in HTF MI database of 64 pages, latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect the gastrointestinal tract in a variety of ways. Opioids increase the amount of time it takesโ€ฆ
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017, provides an overview of the Opioid-Induced Constipation (OIC) (Oncology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affectโ€ฆ
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2016
Global Markets Directs, Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2016, provides an overview of the Opioid-Induced Constipation (OIC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and developmentโ€ฆ